Biography
I graduated from Clermont-Ferrand University in 2001. I started my career at Seppic China in 2004 as Sales Engineer for Vaccine Adjuvants and Injectable and was then appointed as China Sales Manager for SEPPIC Vaccine Adjuvants where I participated in the growth of SEPPIC business in China with the construction of a new adjuvant plant.
I was then relocated in Singapore with Seppic in 2008 as Regional Business Manager for the North Asia, South East Asia and Pacific area where I developed sales and provided technical follow up for the veterinary and human market as well as pharmaceutical excipients. In May 2012, I was appointed as Asia Business Manager for SEPPIC adjuvants and Pharmaceutical business unit until 2016. After 4 years spent in Korea as Senior Procurement manager for Electronics Specialty gases, I am now back to SEPPIC from August 2020 as South East Asia Country Manager. I am based in Singapore, managing and developing all the business lines of SEPPIC in the region of South East Asia and Pacific with my team. Research interests
I am interested to be involved in vaccine research happening in South East Asia Pacific requiring vaccine adjuvants for any species and any route of deliveries being Intra muscular, Subcutaneous, Intradermal, Orally, Sprayable, In-Ovo, etc.. SEPPIC provides a selection of adjuvant tailor-made for each vaccine project free of charge. Our purpose is to work together with researchers by providing free sampling, technical discussion, field trials until the vaccine is registered and start to be produced at commercial scale. Projects you're working on
SEPPIC is working with various researchers and vaccine companies around the world. I focus only on South East Asia and Pacific region. Discipline
Commercialisation Formulation technology Immunology – B-cells Immunology – T-cells Immunology – innate Host species
Buffalo Camels Cats Cattle Dogs Fish Horses Pigs Poultry Small ruminants Wildlife Zoonoses Pathogen
Bacteria Bacteria›Aeromonas Bacteria›Brucella Bacteria›Chlamydophila Bacteria›Clostridia Bacteria›Corynebacterium Bacteria›E. coli Bacteria›Erysipelas Bacteria›Leptospira Bacteria›M. hyo Bacteria›Mycobacteria bovis Bacteria›Mycoplasma Bacteria›Salmonella Bacteria›Yersinia Parasites Parasites›Babesia Parasites›Cestodes Parasites›Eimeria Parasites›Nematodes Parasites›Neospora Parasites›Taenia solium Parasites›Theileria annulata Parasites›Theileria parva Parasites›Ticks Parasites›Trypanosoma Viruses Viruses›Adenovirus Viruses›African horse sickness virus Viruses›African swine fever virus Viruses›Arboviruses Viruses›Arteriviruses Viruses›Avian papillomavirus Viruses›Avian polyomavirus Viruses›Bluetongue virus Viruses›Bovine ephemeral fever virus Viruses›Bovine viral diarrhoea Viruses›Calicivirus Viruses›Capripoxvirus Viruses›Chicken anaemia virus Viruses›Classical swine fever virus Viruses›Coronavirus Viruses›Crimean-Congo haemorrhagic fever virus Viruses›Cytomegalovirus Viruses›Ebolaviruses/filoviruses Viruses›Feline leukaemia virus Viruses›Foot-and-mouth disease virus Viruses›Herpesvirus Viruses›Infectious bursal disease virus Viruses›Infectious pancreatic necrosis virus Viruses›Infectious salmon anaemia virus Viruses›Influenza virus Viruses›Mareks disease virus Viruses›Nairoviruses Viruses›Newcastle disease virus Viruses›Nipah virus Viruses›Parainfluenza virus Viruses›Paramyxoviruses Viruses›Parvovirus Viruses›Peste des petits ruminants virus Viruses›Piscine novirhabdovirus Viruses›Porcine circovirus Viruses›Porcine reproductive and respiratory syndrome virus Viruses›Poxviruses Viruses›Rabies virus Viruses›Respiratory syncytial virus Viruses›Retroviruses Viruses›Rift Valley fever virus Viruses›Rotavirus Stage of vaccine development
Adjuvants Commercialisation Field trials Marketing Pre-clinical trials Vaccine delivery